BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19008312)

  • 1. A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells.
    You J; Mi D; Zhou X; Qiao L; Zhang H; Zhang X; Ye L
    Endocrinology; 2009 Apr; 150(4):1607-17. PubMed ID: 19008312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2.
    Zhou X; Liu Y; You J; Zhang H; Zhang X; Ye L
    Cancer Lett; 2008 Nov; 270(2):312-27. PubMed ID: 18710790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway.
    Jiao D; Zhang XD
    Oncol Rep; 2016 Jul; 36(1):342-8. PubMed ID: 27122002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis toxin-sensitive heterotrimeric G(αi/o) proteins mediate WNT/β-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A.
    Halleskog C; Schulte G
    Cell Signal; 2013 Apr; 25(4):822-8. PubMed ID: 23266471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cell-substrate adhesion by arachidonic acid: lipoxygenase regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH-3T3 fibroblasts.
    Stockton RA; Jacobson BS
    Mol Biol Cell; 2001 Jul; 12(7):1937-56. PubMed ID: 11451994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction pathways for activation of extracellular signal-regulated kinase by arachidonic acid in rat neutrophils.
    Chang LC; Wang JP
    J Leukoc Biol; 2001 Apr; 69(4):659-65. PubMed ID: 11310854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC‑α/ERK1/2 pathway: An in vitro investigation.
    Cheng XD; Gu JF; Yuan JR; Feng L; Jia XB
    Mol Med Rep; 2015 Dec; 12(6):7992-8002. PubMed ID: 26498639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The signalling profile of recombinant human orexin-2 receptor.
    Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
    Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
    J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors.
    Kanazawa T; Iwashita T; Kommareddi P; Nair T; Misawa K; Misawa Y; Ueda Y; Tono T; Carey TE
    Oncogene; 2007 Aug; 26(39):5762-71. PubMed ID: 17384686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN sustains high growth of breast cancer cells.
    Hu N; Li Y; Zhao Y; Wang Q; You JC; Zhang XD; Ye LH
    Acta Pharmacol Sin; 2011 Jul; 32(7):921-9. PubMed ID: 21643005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadmium-induced hormetic effect in differentiated Caco-2 cells: ERK and p38 activation without cell proliferation stimulation.
    Mantha M; Jumarie C
    J Cell Physiol; 2010 Jul; 224(1):250-61. PubMed ID: 20232314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.
    Zheng A; Kallio A; Härkönen P
    Endocrinology; 2007 Jun; 148(6):2764-77. PubMed ID: 17363451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.